Valneva provides update on european inactivated, whole-virus covid-19 vaccine program vla2001

Saint-herb lain (france ) , june 1 0 , 2 02 2 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today provides an update on its european inactivated whole-virus covid-19 vaccine candidate vla2001. following receipt of the european commission (ec)'s notice of intent to terminate the advance purchase agreement (apa)1, valneva proposed a remediation plan, which is now subject to further discussion within the ec and among the participating member states.
VALN Ratings Summary
VALN Quant Ranking